PARNF — Parnell Pharmaceuticals Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $10.74m
- AU$13.17m
Annual cashflow statement for Parnell Pharmaceuticals Holdings, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2012 June 30th | 2013 June 30th | 2014 June 30th | 2015 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Changes in Working Capital | 0.027 | 0.007 | 0.024 | 0.009 |
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 3.56 | -2.98 | -11.5 | -16.4 |
| Capital Expenditures | -5.21 | -2.96 | -1.92 | -9.55 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0 | 0.544 | 1.44 | 1.67 |
| Sale of Fixed Assets | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -5.21 | -2.41 | -0.483 | -7.88 |
| Financing Cash Flow Items | -0.68 | -0.68 | -5.11 | 0 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.01 | 6.17 | 31.9 | 12.1 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.645 | 0.781 | 19.9 | -10.2 |